Takeda Pharmaceuticals U.S.A., Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Takeda Pharmaceuticals U.S.A., Inc..The latest application filed is for "methods of treatment and compositions with xanthine oxidase inhibitors".

Company Profile

0.25.17

Takeda Pharmaceuticals U.S.A., Inc. - Deerfield IL
Takeda Pharmaceuticals U.S.A., Inc. - DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods Of Treatment And Compositions With Xanthine Oxidase Inhibitors App 20180311217 - Gunawardhana; Lhanoo ; et al.	2018-11-01
Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity App 20180161321 - Moore; Nicholas ; et al.	2018-06-14
Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors Grant 9,937,157 - Taneja , et al. April 10, 2	2018-04-10
Multiple PPI dosage form Grant 9,889,152 - Taneja , et al. February 13, 2	2018-02-13
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy Grant 9,889,125 - Lee February 13, 2	2018-02-13
Novel Modified Release Dosage Forms Of Xanthine Oxidoreductase Inhibitor Or Xanthine Oxidase Inhibitors App 20160317505 - Taneja; Rajneesh ; et al.	2016-11-03
Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity App 20160228430 - Moore; Nicholas ; et al.	2016-08-11
Colchicine solid-state forms; methods of making; and methods of use thereof Grant 9,255,063 - Sun , et al. February 9, 2	2016-02-09
Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors Grant 9,248,119 - Taneja , et al. February 2, 2	2016-02-02
Multiple PPI dosage form Grant 9,238,029 - Taneja , et al. January 19, 2	2016-01-19
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy Grant 9,233,103 - Lee January 12, 2	2016-01-12
Methods for concomitant treatment of theophylline and febuxostat Grant 9,107,912 - Gunawardhana , et al. August 18, 2	2015-08-18
Colchicine Formulations; Methods Of Making; And Methods Of Use Thereof App 20150164831 - Roberts; Richard H. ; et al.	2015-06-18
Methods Of Treatment And Compositions With Xanthine Oxidase Inhibitors App 20140357683 - Gunawardhana; Lhanoo ; et al.	2014-12-04
Methods For Treating Hypertension App 20140329868 - Lademacher; Christopher ; et al.	2014-11-06
Methods for treating nephrolithiasis Grant 8,841,333 - Joseph-Ridge September 23, 2	2014-09-23
Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues Grant 8,785,491 - Baron , et al. July 22, 2	2014-07-22
Methods For Administration Of Colchicine With Grapefruit Juice App 20140107213 - Davis; Matthew W.	2014-04-17
Colchicine Compositions And Methods App 20140037550 - Davis; Matthew W. ; et al.	2014-02-06
Multiple Ppi Dosage Form App 20130245071 - Taneja; Rajneesh ; et al.	2013-09-19
Colchicine solid complex; methods of making; and methods of use thereof Grant 8,519,002 - Sun , et al. August 27, 2	2013-08-27
Thiocolchicine derivatives, method of making and methods of use thereof Grant 8,497,290 - Manchanda July 30, 2	2013-07-30
Methods For Treating Hypertension In Black Patients App 20130158080 - Kupfer; Stuart	2013-06-20
Multiple PPI dosage form Grant 8,461,187 - Taneja , et al. June 11, 2	2013-06-11
Methods For Preserving And/or Increasing Renal Function Using Xanthine Oxidoreductase Inhibitors App 20130143886 - Lademacher; Christopher ; et al.	2013-06-06
Methods for concomitant administration of colchicine and a second active agent Grant 8,445,541 - Davis May 21, 2	2013-05-21
Methods for concomitant administration of colchicine and a second active agent Grant 8,440,721 - Davis May 14, 2	2013-05-14
Colchicine compositions and methods Grant 8,415,395 - Davis , et al. April 9, 2	2013-04-09
Colchine compositions and methods Grant 8,415,396 - Davis , et al. April 9, 2	2013-04-09
Methods for concomitant treatment of theophylline and febuxostat Grant 8,372,872 - Gunawardhana , et al. February 12, 2	2013-02-12
Sorbitol/dexlansoprazole co-crystals and method for making same Grant 8,318,943 - Sun , et al. November 27, 2	2012-11-27
Methods For Treating Heartburn And/or Preventing Gastric Bleeding Or Hemorrhage In Patients Receiving Clopidogrel Therapy App 20120245203 - Lee; Ronald D.	2012-09-27
Methods of treating gastrointestinal disorders independent of the intake of food Grant 8,173,158 - Lee , et al. May 8, 2	2012-05-08

Company Registrations

NCAGE Code	7ERY5	TAKEDA PHARMACEUTICALS U.S.A., INC
CAGE Code	7ERY5	TAKEDA PHARMACEUTICALS U.S.A., INC
SEC	0001716229	Takeda Pharmaceuticals U.S.A., Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.